blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1896500

EP1896500 - GLIOMEDIN, FRAGMENTS THEREOF AND METHODS OF USING SAME [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  01.06.2012
Database last updated on 12.10.2024
Most recent event   Tooltip01.06.2012Application deemed to be withdrawnpublished on 04.07.2012  [2012/27]
Applicant(s)For all designated states
YEDA RESEARCH AND DEVELOPMENT CO., LTD.
The Weizmann Institute of Science P.O. Box 95
76100 Rehovot / IL
[2008/11]
Inventor(s)01 / PELES, Elior
56 Carmel Street
73605 Rehovot / IL
02 / ESHED, Yael
P.O. Box 909
83109 Moshav Orot / IL
 [2008/11]
Representative(s)Becker Kurig & Partner Patentanwälte mbB
Bavariastraße 7
80336 München / DE
[N/P]
Former [2008/11]Becker Kurig Straus
Patentanwälte Bavariastrasse 7
80336 München / DE
Application number, filing date06756231.428.06.2006
[2008/11]
WO2006IL00753
Priority number, dateUS20050694438P28.06.2005         Original published format: US 694438 P
US20050696782P07.07.2005         Original published format: US 696782 P
[2008/11]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2007000768
Date:04.01.2007
Language:EN
[2007/01]
Type: A2 Application without search report 
No.:EP1896500
Date:12.03.2008
Language:EN
The application published by WIPO in one of the EPO official languages on 04.01.2007 takes the place of the publication of the European patent application.
[2008/11]
Search report(s)International search report - published on:US09.04.2009
(Supplementary) European search report - dispatched on:EP14.07.2010
ClassificationIPC:C07K14/00, A61K38/00, C07K14/78
[2010/31]
CPC:
C07K14/78 (EP,US); A61P25/00 (EP); C07K16/18 (EP,US);
G01N33/6896 (EP,US); G01N2333/705 (EP,US)
Former IPC [2009/23]C07K14/00, A61K38/00
Former IPC [2008/11]C07K14/705
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2008/11]
Extension statesRSNot yet paid
TitleGerman:GLIOMEDIN, FRAGMENTE DAVON UND VERFAHREN ZU IHRER ANWENDUNG[2008/11]
English:GLIOMEDIN, FRAGMENTS THEREOF AND METHODS OF USING SAME[2008/11]
French:GLIOMÉDINE: FRAGMENTS ET PROCÉDÉS[2008/11]
Entry into regional phase04.12.2007National basic fee paid 
04.12.2007Search fee paid 
04.12.2007Designation fee(s) paid 
04.12.2007Examination fee paid 
Examination procedure04.12.2007Examination requested  [2008/11]
31.01.2011Amendment by applicant (claims and/or description)
30.12.2011Application deemed to be withdrawn, date of legal effect  [2012/27]
10.02.2012Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2012/27]
Fees paidRenewal fee
12.06.2008Renewal fee patent year 03
16.06.2009Renewal fee patent year 04
11.06.2010Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
30.06.201106   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[AD]US6569423  (WEINSTEIN DAVID E [US]) [AD] 1;
 [Y]  - "RecName: Full=Gliomedin;", UniProt, (20040705), Database accession no. Q6ZMI3, URL: EBI, XP002589492 [Y] 1-15 * the whole document *
 [Y]  - "COLM", UniProt, (20031001), Database accession no. Q7z359, URL: EBI, XP002589493 [Y] 1-15 * the whole document *
 [YD]  - "Mus musculus olfactomedin-related protein (Crgl2) mRNA, complete cds.", EMBL, (20030303), Database accession no. AF548022, URL: EBI, XP002589494 [YD] 1-15 * the whole document *
 [XDY]  - GRAVEEL CARRIE R ET AL, "Identification and characterization of CRG-L2, a new marker for liver tumor development", ONCOGENE, NATURE PUBLISHING GROUP, GB LNKD- DOI:10.1038/SJ.ONC.1206309, (20030320), vol. 22, no. 11, ISSN 0950-9232, pages 1730 - 1736, XP002395830 [XD] 1-3,9,10 * the whole document * [Y] 1-15

DOI:   http://dx.doi.org/10.1038/sj.onc.1206309
 [YD]  - LORIA PAULA M ET AL, "A conserved postsynaptic transmembrane protein affecting neuromuscular signaling in Caenorhabditis elegans.", JOURNAL OF NEUROSCIENCE, (20040303), vol. 24, no. 9, ISSN 0270-6474, pages 2191 - 2201, XP002589495 [YD] 1-3,9-15 * page 2196, column r; figure 3 4 *
 [Y]  - "gliomedin", UniProt, (20030601), Database accession no. Q80WL1, URL: ebi, XP002589496 [Y] 1-15 * the whole document *
 [Y]  - FRANZKE CLAUS-WERNER ET AL, "Collagenous transmembrane proteins: Recent insights into biology and pathology", JOURNAL OF BIOLOGICAL CHEMISTRY, (20050211), vol. 280, no. 6, ISSN 0021-9258, pages 4005 - 4008, XP002589497 [Y] 1-15 * page 4005, column r *

DOI:   http://dx.doi.org/10.1074/jbc.R400034200
 [I]  - "Human NOVX protein encoding cDNA sequence, SEQ ID No 41.", Geneseq, (20031218), Database accession no. ADC13562, URL: EBI, XP002589498 [I] 3,6,9,10 * the whole document *
 [I]  - "Human novel cDNA sequence, SEQ ID NO:799.", Geneseq, (20031218), Database accession no. ADC30717, URL: EBI, XP002589499 [I] 3,6,9,10 * compound . *
 [XDP]  - ESHED YAEL ET AL, "Gliomedin mediates Schwann cell-axon interaction and the molecular assembly of the nodes of Ranvier", NEURON, (200507), vol. 47, no. 2, ISSN 0896-6273, pages 215 - 229, XP002589500 [XDP] 1-24 * the whole document *

DOI:   http://dx.doi.org/10.1016/J.NEURON.2005.06.026
International search[X]US2005074762  (NAKAMURA YUSUKE [JP], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.